Korekiyo Wakitani

A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

Hiroshi Okamoto, Fumihiko Yonemori, Korekiyo Wakitani et al. · Nature · 2000 · 526 citations

Metabolic Syndrome, Oxysterol, Biochemistry +12

4-(4-Cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as Selective Cyclooxygenase-2 Inhibitors:  Enhancement of the Selectivity by Introduction of a Fluorine Atom and Identification of a Potent, Highly Selective, and Orally Active COX-2 Inhibitor JTE-522

Hiromasa Hashimoto, Katsuaki Imamura, Jun‐ichi Haruta et al. · Journal of Medicinal Chemistry · 2002 · 121 citations · Full text

Bioorganic Chemistry, Pharmacotherapy, Selective Cyclooxygenase-2 Inhibitors +17

Effects of peroxisome proliferator‐activated receptor‐α and ‐γ agonist, JTT‐501, on diabetic complications in Zucker diabetic fatty rats

Tsutomu Shibata, Satomi Takeuchi, Seiko Yokota et al. · British Journal of Pharmacology · 2000 · 90 citations · Full text

Isoxazolidine-3,5-dione and Noncyclic 1,3-Dicarbonyl Compounds as Hypoglycemic Agents

Hisashi Shinkai, Syoji Onogi, Masahiro Tanaka et al. · Journal of Medicinal Chemistry · 1998 · 76 citations

Pharmaceutical Science, Noncyclic 1,3-Dicarbonyl Compounds, Organic Chemistry +16

Pharmacological Studies on the TXA2 Synthetase Inhibitor (E)-3-[p(1H-lmidazol-1-Ylmethyl)Phenyl]-2-Propenoic Acid (OKY-046)

Seiji HIRAKU, Ken Taniguchi, Korekiyo Wakitani et al. · The Japanese Journal of Pharmacology · 1986 · 63 citations · Full text